Pure Global
NCT06299332

Safety and Efficacy of Bi-Polar Radiofrequency for the Treatment of Erectile Dysfunction

InMode MD Ltd.·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Erectile Dysfunction
Drug/Device/Intervention
Device treatment
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
InMode MD Ltd.
Location
New York,New York, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jun 23, 2023
End date
May 01, 2025
Enrollment
20 participants
Primary outcome

Change in ED symptoms, following the RF treatment

Summary

The goal of this prospective pilot study is to learn about the Safety and Efficacy of
 Radiofrequency (RF) for the Treatment of Erectile Dysfunction. This research study is trying
 to determine if RF therapy is safe and effective in patients with symptoms of erectile
 dysfunction (ED).

ICD-10 classifications
Orgasmic dysfunctionOther disorders of penisOther specified disorders of penisSexual dysfunction, not caused by organic disorder or diseaseTesticular dysfunction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06299332
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06299332 through Pure Global AI's free database. This phase not specified trial is sponsored by InMode MD Ltd. and is currently Recruiting. The study focuses on Erectile Dysfunction. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.